Navigation Links
Sedative Could Be Deadly in People With Seizures
Date:10/28/2008

At high doses, propofol tied to cardiac arrest in patients with a form of epilepsy

TUESDAY, Oct. 28 (HealthDay News) -- Use of the sedative propofol is associated with a high risk for complications and even death in patients with prolonged seizures, according to a study by researchers at the Mayo Clinic in Rochester, Minn.

The study included 39 patients with refractory status epilepticus (RSE) -- prolonged seizures that don't respond to initial treatment. The condition occurs in patients with primary epilepsy and in those with other conditions such as trauma, tumors and infections that affect the brain.

Propofol is used to treat patients with RSE, but is more commonly used for sedation during surgery or other patient procedures. In those situations, propofol is used at a much lower dose and shorter duration than when it's used to treat RSE, according to background information in an American College of Chest Physicians news release on the Mayo study.

"Patients with RSE treated with propofol are at high risk for propofol-related side effects because of the high propofol infusion rates and prolonged treatment duration necessary in these patients. However, it is well described that propofol toxicity can occur even with brief exposure to the drug," study author Dr. Vivek Iyer, of the Mayo Clinic, said in the news release.

In the study, 39 patients (average age 54) were admitted to the intensive care unit with RSE. Thirty-two received propofol for a median of 63 hours and a median peak infusion rate of 67 micrograms per kilogram per minute. The other seven patients received other drugs, such as midazolam and pentobarbital.

In the propofol group, three patients had sudden unexplained cardiac arrest, resulting in two deaths. There were no deaths in the other group.

Thirty percent of patients in the propofol group experienced propofol infusion syndrome (PRIS), a serious complication defined by the unexplained presence of at least one or more of the following: the blood disorder known as metabolic acidosis; rhabdomyolysis (a muscle disorder); bradycardia (lowered heart rate); and/or cardiac arrest. PRIS occurred in one patients in the other group.

The findings indicate that doctors should be cautious in the use of propofol to treat patients with RSE, Iyer said.

"There are several other medications we can turn to in the case of uncontrolled seizures," he said. "Alternative agents should first be tried for patients with RSE, and propofol should only be used after exhausting all other options."

The study was to be presented Tuesday at CHEST 2008, the annual international scientific meeting of the American College of Chest Physicians, in Philadelphia.

More information

The Epilepsy Foundation has more about prolonged seizures.



-- Robert Preidt



SOURCE: American College of Chest Physicians, news release, Oct. 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Newer Sedative Might Help Patients on Ventilators
2. A high-fat diet could promote the development of Alzheimers
3. Antiseizure Drug Could be Fatal
4. Anti-seizure drug could be fatal
5. Common epilepsy drug could prevent and treat Alzheimers disease
6. The Pink Ribbon That Could Save Your Life
7. With the Economy of the United States at a Turning Point, Health Care Could Be Our Next Serious Crisis ...
8. New Advances Could Battle Cancer Cell by Cell
9. Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half
10. New test could help catch serious infections in babies
11. New way to control protein activity could lead to cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sedative Could Be Deadly in People With Seizures
(Date:2/18/2017)... ... February 17, 2017 , ... ... Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 — ... looking to reduce their regulatory burden? Pay dividends in enhanced and predictable ...
(Date:2/18/2017)... California (PRWEB) , ... February 17, 2017 , ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn ... fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new directory from the ... to easily connect elderly veterans of America's armed forces to a range of ... conveys material on this year's increase in the Veterans Pension with Aid & ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance Healthcare ... designed to further positively impact the health and wellness of our community in ... it our duty to seriously consider releasing our assets beyond our 5% targeted ...
(Date:2/17/2017)... , ... February 17, 2017 ... ... Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 ... the critical reimbursement questions manufacturers should be asking before selecting an FDA ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, ... is expected to grow at a CAGR of 9.4% from 2017-2022 ... grow at a CAGR of 9.5% from 2017 to 2027. The ... ... will benefit you Read on to discover how you can ...
(Date:2/17/2017)... , Feb. 17, 2017 Arvinas LLC, ... drugs based on protein degradation, today announced the presentation ... (AR) PROTAC during a poster session at the American ... GU) in Orlando, FL. ... validate our platform and the potential of PROTACs to ...
(Date:2/17/2017)... , Feb 17, 2017 Research and Markets has ... Business Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology: